Results 161 to 170 of about 6,396 (177)
Some of the next articles are maybe not open access.
UGT1A6 Genotype-Related Pharmacokinetics of Deferiprone (L1) in Healthy Volunteers
British Journal of Clinical Pharmacology, 2008Suthat Fucharoen +2 more
exaly
Wound Healing by Topical Application of Antioxidant Iron Chelators: Kojic Acid and Deferiprone.
International Wound Journal, 2013Mohaddeseh Behjati +2 more
exaly
Deferiprone Protects Against Doxorubicin-Induced Myocyte Cytotoxicity
Free Radical Biology and Medicine, 2002Brian B Hasinoff
exaly
Safety of Oral Iron Chelator Deferiprone in Young Thalassaemics
European Journal of Haematology, 2005Rahul Naithani, Jagdish Chandra
exaly
Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded Patients
Blood, 1998Beatrix Wonke +2 more
exaly
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2015
Carlos Fernández +2 more
exaly
Carlos Fernández +2 more
exaly

